Endothel Pharma ApS
CVR 37988936 · Private limited company (ApS) · Active · Medium risk
Endothel Pharma ApS is a Private limited company (ApS), founded on , based in København K. The company is registered in the industry fremstilling af farmaceutiske præparater. Our model estimates a bankruptcy risk of 1.4% over the next 12 months, which is 1.0 times the average for Danish companies. 9 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK -463k and a net result of DKK -87k. CEO: Rikke Stine Friis Fléron.
Bankruptcy risk for Endothel Pharma ApS
1.0 × the average (1.41%) · higher risk than 75% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 37988936
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (10 years)
- Address
- c/o Loeven Advokatfirma, Frederiksgade 19, 3.
1265 København K - Municipality
- København
- Industry
- Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater - Share capital
- DKK 75k
- Auditor
- Beierholm
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 0 of 9 |
| Missing annual report | No |
| Negative equity | Yes |
| Equity ratio | -82.2% |
| Current ratio | 3% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 4 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 51 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK -44k | DKK -42k |
| Net profit | DKK -87k | DKK -82k |
| Equity | DKK -463k | DKK -376k |
| Total assets | DKK 563k | DKK 575k |
| Cash | DKK 31k | – |
| Short-term debt | DKK 1.0m | – |
| Avg. employees | 0 | – |
Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · Beierholm.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 44 | ||
| 1 Jan 2024 – 31 Dec 2024 | 161 | ||
| 1 Jan 2023 – 31 Dec 2023 | 169 | ||
| 1 Jan 2022 – 31 Dec 2022 | 131 | ||
| 1 Jan 2021 – 31 Dec 2021 | 152 | ||
| 1 Jan 2020 – 31 Dec 2020 | 174 | ||
| 1 Jan 2019 – 31 Dec 2019 | 92 | ||
| 1 Jan 2018 – 31 Dec 2018 | 64 | ||
| 31 Aug 2016 – 31 Dec 2017 | 176 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Rikke Stine Friis Fléron | Current | |
| CEO | Leif Helth Jensen | ||
| CEO | Sisse Rye Ostrowski | ||
| Board | Leif Helth Jensen | ||
| Board | Sisse Rye Ostrowski | ||
| Board | Pär Ingemar Johansson | ||
| Owner (50%) | Bo Jesper Hansen | Current | |
| Owner (50%) | Pär Ingemar Johansson | Current | |
| Owner (50%) | Trial-Lab Holding AB | Current | |
| Owner (20%) | Leif Helth Jensen | ||
| Owner (33%) | Sisse Rye Ostrowski | ||
| Owner (33%) | Pär Ingemar Johansson | ||
| Owner (50%) | Sisse Rye Ostrowski | ||
| Owner (50%) | Pär Ingemar Johansson | ||
| Owner (33%) | Bo Jesper Hansen | ||
| Owner (33%) | Sisse Rye Ostrowski | ||
| Owner (33%) | Pär Ingemar Johansson | ||
| Owner (33%) | Trial-Lab Holding AB | ||
| Owner (33%) | DocSRO ApS | ||
| Founder | Leif Helth Jensen | Current | |
| Founder | Sisse Rye Ostrowski | Current | |
| Founder | Pär Ingemar Johansson | Current |
The CEOs' other companies
Leif Helth Jensen – 35 other companies, of which 5 bankrupt
- ALCORLAB A/S Bankrupt 1 Dec 2010
- BLUSENSE DIAGNOSTICS APS Bankrupt 24 May 2023
- HEED DIAGNOSTICS ApS Bankrupt 15 Apr 2016
- MEDITEL A/S Bankrupt 24 May 2000
- SUPER ApS Bankrupt 19 Jan 2016
- Blue Cell Therapeutics ApS Active
- CRITHERAPY ApS Compulsorily dissolved
- CUREON A/S Fusioneret
- DENCORE ApS Fusioneret
- DENTOFIT A/S Opløst
- DRUGRECURE ApS Active
- EXIQON A/S Fusioneret
- GENMAB A/S Active
- GLOBAL AVIATION DATA A/S Active
- HYGIA DIAGNOSTICS ApS Opløst
- INAGEN ApS Opløst
- LEIF HELTH CARE A/S Opløst
- Loma Therapeutics ApS Active
- MICROLYTIC ApS Opløst
- Migalis ApS Active
- NORDIC PATENT SERVICE A/S Active
- NSE ApS Opløst
- OLDBAK ApS Active
- PHARMAORIGIN ApS Active
- PROFOUND INVEST A/S Opløst
- PROMOGENETICS ApS Opløst
- ROSE PHARMA A/S Compulsorily dissolved
- SECURIN ApS Active
- Serenova A/S Opløst
- THROMBOLOGIC ApS Opløst
Address history (1 moves)
| c/o Loeven Advokatfirma, Frederiksgade 19, 3., 1265 København K | |
| c/o Brinkmann Kronborg Henriksen, Amaliegade 15, 1256 København K |
Other companies at the same address
- ARKITEKTFIRMAET CS ApS Bankrupt
- ENTREPRENØRFIRMAET SIMONSEN ApS KBIL 38 NR. 1194 Bankrupt
- 01.09.93 A/S Opløst
- A FINANS ApS Active
- ARCH RE UNDERWRITING ApS Active
- ApS AF 10/4 1995 Opløst
- ApS AF 29.4.1977 Opløst
- Aquarius Holding ApS Active
- BARFOD LINE ApS Opløst
- C-Real Troldebakkerne II, Private placement II ApS Active
- CLIFTON TECHNOLOGIES ApS Active
- Carlo HoldCo ApS Active
- Connect Recruitment ApS Active
- DAN LAURIDSEN ApS Opløst
- DENTAX INTERNATIONAL ApS Opløst
- Duffel Music ApS Active
- EJENDOMSAKTIESELSKABET "SCHNEEKLOTHSVEJ NR. 3 M.FL" Opløst
- EJENDOMSAKTIESELSKABET MALMMOSEN Opløst
- EKONOMIFILTER A/S Opløst
- ERHVERVSINVESTERING AF 11/11 1979 I ApS Compulsorily dissolved
- EUROMED A/S Opløst
- Elemental DK ApS Active
- F.M. METALVAREFABRIK ApS Compulsorily dissolved
- FINANSIERINGSSELSKABET AF 1/5 1995 ApS Opløst
- FJELL INVEST AKTIESELSKAB Compulsorily dissolved
Similar companies in København
- H. LUNDBECK A/S Valby
- GUNNAR KJEMS ApS København K
- Tetrapharm Therapeutics ApS København S
- Tetrapharm Bioengineering ApS København S
- Luvalis Pharma ApS Vanløse
- NeuroVersis Therapeutics ApS København K
- QuantumCell ApS København K
- Vautia Therapeutics ApS København K
- Corxel Pharmaceuticals Denmark ApS København V
- Dispersome IP ApS København Ø
- Maddox Pharma Swiss ApS København S
- Gefjon Pharma ApS København N
Questions and answers about Endothel Pharma ApS
Has Endothel Pharma ApS gone bankrupt?
No, Endothel Pharma ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Endothel Pharma ApS?
Our model estimates a bankruptcy risk of 1.4% over the next 12 months (medium risk), which is 1.0 times the average for Danish companies.
Who is the CEO of Endothel Pharma ApS?
Rikke Stine Friis Fléron is the CEO of Endothel Pharma ApS.
Who is the auditor of Endothel Pharma ApS?
Endothel Pharma ApS most recently used Beierholm.
When was Endothel Pharma ApS founded?
Endothel Pharma ApS was founded on 31 August 2016.
What is the equity of Endothel Pharma ApS?
Equity was DKK -463k according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.